Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
6.95 USD
1.40 B USD
6.00 B USD
579.55 M
About Edwards Lifesciences Corporation
Sector
Industry
CEO
Bernard J. Zovighian
Website
Headquarters
Irvine
Founded
1958
FIGI
BBG000BRXP69
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EW is 74.12 USD — it has increased by 0.80% in the past 24 hours. Watch Edwards Lifesciences Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Edwards Lifesciences Corporation stocks are traded under the ticker EW.
EW stock has risen by 3.23% compared to the previous week, the month change is a 13.17% rise, over the last year Edwards Lifesciences Corporation has showed a −3.55% decrease.
We've gathered analysts' opinions on Edwards Lifesciences Corporation future price: according to them, EW price has a max estimate of 90.00 USD and a min estimate of 68.00 USD. Watch EW chart and read a more detailed Edwards Lifesciences Corporation stock forecast: see what analysts think of Edwards Lifesciences Corporation and suggest that you do with its stocks.
EW stock is 1.34% volatile and has beta coefficient of 1.12. Track Edwards Lifesciences Corporation stock price on the chart and check out the list of the most volatile stocks — is Edwards Lifesciences Corporation there?
Today Edwards Lifesciences Corporation has the market capitalization of 43.59 B, it has increased by 1.91% over the last week.
Yes, you can track Edwards Lifesciences Corporation financials in yearly and quarterly reports right on TradingView.
Edwards Lifesciences Corporation is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
EW earnings for the last quarter are 0.67 USD per share, whereas the estimation was 0.66 USD resulting in a 0.81% surprise. The estimated earnings for the next quarter are 0.55 USD per share. See more details about Edwards Lifesciences Corporation earnings.
Edwards Lifesciences Corporation revenue for the last quarter amounts to 1.35 B USD, despite the estimated figure of 1.54 B USD. In the next quarter, revenue is expected to reach 1.36 B USD.
EW net income for the last quarter is 3.07 B USD, while the quarter before that showed 366.30 M USD of net income which accounts for 738.33% change. Track more Edwards Lifesciences Corporation financial stats to get the full picture.
No, EW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 19.80 K employees. See our rating of the largest employees — is Edwards Lifesciences Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Edwards Lifesciences Corporation EBITDA is 1.75 B USD, and current EBITDA margin is 30.22%. See more stats in Edwards Lifesciences Corporation financial statements.
Like other stocks, EW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Edwards Lifesciences Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Edwards Lifesciences Corporation technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Edwards Lifesciences Corporation stock shows the sell signal. See more of Edwards Lifesciences Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.